Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8912199

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8911722

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8911752

    Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8912146

    Derivatives of APF and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8912175

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8912316

    Compositions and methods for inhibiting expression of CD45 gene

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8911718

    Methods for preparing polymeric reagents

    Nektar Therapeutics · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8912326

    Process of making gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 2014371251

    METHOD OF INHIBITING DYRK1B

    4SC DISCOVERY GMBH [DE] · Granted Thu Dec 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8916549

    Thienooxazepine derivative

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8916551

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8916556

    Pharmaceutical formulations comprising neurotrophin mimetics

    The United States of America represented by the Department of Vetran Affairs · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8916566

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8916580

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8916596

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8916606

    Therapeutic compositions and methods for targeted delivery of active agents

    The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8916519

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8916184

    Artificial tissue systems and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8916175

    Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8916172

    MVA expressing modified HIV envelope, gag, and pol genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8916197

    Bone marrow-directing drug delivery materials and their applications

    The Board of Regents of the University of Texas System · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8916529

    Oligonucleotide-containing pharmacological compositions and their use

    Lakewood Amedex, Inc. · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8916538

    Solid forms of a thiophosphoramidate nucleotide prodrug

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8916570

    A3 adenosine receptor agonists and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8916528

    Compositions containing resveratrol and nucleotides

    RESVERATROL PARTNERS, LLC · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8916693

    Monoconjugated chitosans as delivery agents for small interfering nucleic acids

    Nektar Therapeutics · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8916603

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8916565

    Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 2014378455

    NEW USE OF 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

    ACRAF [IT] · Granted Thu Dec 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8921536

    HCV vaccines and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8921050

    Methods of diagnosing renal cell carcinoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8921396

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8921395

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8921376

    Pyrrolopyridines useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8921371

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8921393

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8921354

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8920373

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8921372

    Inhibitors of hepatitis C virus

    Theravance Biopharma R&D IP, LLC · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8920625

    Electrochemical method of making porous particles using a constant current density

    The Board of Regents of the University of Texas System · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8920807

    Vault complexes for cytokine delivery

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8920812

    Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

    Takeda Vaccines, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8920848

    Use of cellular extracts for skin rejuvenation

    REGENICS AS · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8920800

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8920840

    Enteric tablet

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8920867

    Methods of forming self-supporting films for delivery of therapeutic agents

    Covidien LP · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.